이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Takara Bio 관리

관리 기준 확인 2/4

Takara Bio's CEO는 Koichi Nakao, May2009 에 임명되었습니다 의 임기는 15.08 년입니다. 는 ¥ 72.16M 가치에 해당하는 회사 주식의 0.06% 직접 소유합니다. 72.16M. 경영진과 이사회의 평균 재임 기간은 각각 2.4 년과 5.5 년입니다.

주요 정보

Koichi Nakao

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	15.1yrs
CEO 소유권	0.06%
경영진 평균 재임 기간	2.4yrs
이사회 평균 재임 기간	5.5yrs

최근 관리 업데이트

Recent updates

CEO

Koichi Nakao (62 yo)

15.1yrs

테뉴어

Mr. Koichi Nakao has been the President of Takara Bio Inc. since May 2009 and serves as its Chief Executive Officer. Mr. Nakao served as the Chief Operating Officer of Takara Bio Inc. He serves as the Chai...

리더십 팀

이름	위치	테뉴어	보상	소유권
Koichi Nakao	CEO, President & Representative Director	15.1yrs	데이터 없음	0.060% ¥ 73.0m
Yoh Hamaoka	CFO, Senior Executive Officer & Director	2.4yrs	데이터 없음	0.014% ¥ 17.2m
Tsuyoshi Miyamura	Senior Executive Officer & Director	10yrs	데이터 없음	0.010% ¥ 12.2m
Junichi Mineno	VP, Executive Officer & Director	2.4yrs	데이터 없음	0.012% ¥ 14.6m
Katsuhiko Kusakabe	CMCO, Senior Executive Officer & Director	7yrs	데이터 없음	0.0025% ¥ 3.0m
Andrew Farmer	Head of Research and Development	no data	데이터 없음	데이터 없음
Akira Kodera	Managing Executive Officer	1.4yrs	데이터 없음	데이터 없음
Kyoko Nakajima	Managing Executive Officer	1.4yrs	데이터 없음	데이터 없음
Nukaya Ikuei	Executive Officer	less than a year	데이터 없음	데이터 없음
Ikuei Nukaya	Managing Executive Officer	less than a year	데이터 없음	데이터 없음

2.4yrs

평균 재임 기간

경험이 풍부한 관리: 4974 의 관리팀은 경험 ( 2.4 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Koichi Nakao	CEO, President & Representative Director	9yrs	데이터 없음	0.060% ¥ 73.0m
Yoh Hamaoka	CFO, Senior Executive Officer & Director	3yrs	데이터 없음	0.014% ¥ 17.2m
Tsuyoshi Miyamura	Senior Executive Officer & Director	6yrs	데이터 없음	0.010% ¥ 12.2m
Junichi Mineno	VP, Executive Officer & Director	10yrs	데이터 없음	0.012% ¥ 14.6m
Katsuhiko Kusakabe	CMCO, Senior Executive Officer & Director	1.4yrs	데이터 없음	0.0025% ¥ 3.0m
Mutsumi Kimura	Director	2yrs	데이터 없음	0.042% ¥ 51.3m
Masahide Tamaki	Full-Time Auditor	5yrs	데이터 없음	0.0050% ¥ 6.1m
Kazuko Kimura	Independent External Director	5yrs	데이터 없음	데이터 없음
Akihiko Kita	Full-Time Auditor	8yrs	데이터 없음	0.0013% ¥ 1.6m
Nobuko Kawashima	Independent External Director	8yrs	데이터 없음	데이터 없음
Yasuo Himeiwa	External Auditor	8yrs	데이터 없음	데이터 없음
Noriomi Matsumura	Independent External Director	4yrs	데이터 없음	데이터 없음

5.5yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: 4974 의 이사회는 경험(평균 재직 기간 5.5 년)으로 간주됩니다.

Takara Bio 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Takara Bio Inc., Annual General Meeting, Jun 21, 2024

Takara Bio Inc., Annual General Meeting, Jun 23, 2023

Less than half of directors are independent

Takara Bio Inc., Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

Recent updates

Takara Bio Inc. to Report Q1, 2025 Results on Aug 08, 2024

Full year 2024 earnings: EPS and revenues miss analyst expectations

Takara Bio Inc., Annual General Meeting, Jun 21, 2024

Consensus EPS estimates fall by 30%

Takara Bio Inc. Proposes Dividend for the Fiscal Year Ending March 31, 2024, Effective June 24, 2024

Consensus EPS estimates fall by 56%

Price target decreased by 17% to JP¥1,600

Upcoming dividend of JP¥17.00 per share

Takara Bio Inc.(TSE:4974) dropped from FTSE All-World Index (USD)

Takara Bio Inc. to Report Fiscal Year 2024 Results on May 10, 2024

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates increase by 29%, revenue downgraded

Takara Bio Inc. to Report Q3, 2024 Results on Feb 14, 2024

Consensus EPS estimates fall by 15%

Price target decreased by 17% to JP¥1,933

Takara Bio Inc. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Takara Bio Inc. to Report Q2, 2024 Results on Nov 09, 2023

Takara Bio Inc. to Report Q2, 2024 Results on Nov 14, 2023

Now 20% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Takara Bio Inc. to Report Q1, 2024 Results on Aug 08, 2023

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Takara Bio Inc., Annual General Meeting, Jun 23, 2023

Upcoming dividend of JP¥42.00 per share at 2.3% yield

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Takara Bio Inc. Provides Dividend Guidance for the Fiscal Year Ending Mar. 31, 2023

Takara Bio Inc. to Report Q3, 2023 Results on Feb 09, 2023

Price target decreased to JP¥2,250

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Takara Bio Inc. Provides Dividend Guidance for the Fiscal Year Ending Mar. 31, 2023

Takara Bio Inc. to Report Q2, 2023 Results on Nov 10, 2022

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to JP¥2,400

Takara Bio Inc. to Report Q1, 2023 Results on Aug 04, 2022

Price target decreased to JP¥2,515

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Takara Bio Inc., Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

Takara Bio Inc. to Report Fiscal Year 2022 Results on May 12, 2022

Upcoming dividend of JP¥30.00 per share

Consensus revenue estimates increase by 16%

Price target decreased to JP¥2,742

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to JP¥2,792

Price target decreased to JP¥3,012

Second quarter 2022 earnings released: EPS JP¥33.09 (vs JP¥15.53 in 2Q 2021)

Consensus EPS estimates increase to JP¥91.00

First quarter 2022 earnings released: EPS JP¥50.04 (vs JP¥3.36 in 1Q 2021)

Takara Bio Inc. Provides Earnings Guidance for the Six Months Ending September 30, 2021; Provides Earnings Guidance for the Year Ending March 31, 2022

Full year 2021 earnings released: EPS JP¥79.28 (vs JP¥31.72 in FY 2020)

Upcoming dividend of JP¥14.00 per share

Takara Bio Inc. to Report Fiscal Year 2021 Results on May 13, 2021

Analysts increase EPS estimates to JP¥53.65

Third quarter 2021 earnings released: EPS JP¥28.67 (vs JP¥5.26 in 3Q 2020)

New 90-day high: JP¥3,045

New 90-day low: JP¥2,752

Takara Bio Inc. to Report Q3, 2021 Results on Feb 10, 2021

New 90-day high: JP¥3,020

Takara Bio Inc. to Report Q2, 2021 Results on Nov 10, 2020

CEO

테뉴어

리더십 팀

평균 재임 기간

이사회 구성원

평균 재임 기간